{"entity":{"type":"insider","cik":"0001625579","url":"/insider/0001625579","json_url":"/insider/0001625579.json","name":"Granger Elder","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2021-06-28","last":"2025-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Granger Elder","source":"filing","n_filings":8,"first_seen":"2021-06-28","last_seen":"2025-03-17"}],"transactions":[{"id":4049335,"accession":"0001225208-25-003437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-003437","line_url":"/filing/0001225208-25-003437#line-2","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Cigna Group","issuer_ticker":"CI","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock, $.01 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":310.35,"price_display":"310.35","price_state":"stated","total_value":737391.6,"total_display":"737,391.60","shares_owned_after":5471.0,"shares_owned_after_display":"5,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-17","scope":"insider"},{"id":3173369,"accession":"0001225208-24-006915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-006915","line_url":"/filing/0001225208-24-006915#line-2","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Cigna Group","issuer_ticker":"CI","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock, $.01 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":547.0,"shares_display":"547","price_per_share":331.38,"price_display":"331.38","price_state":"stated","total_value":181264.86,"total_display":"181,264.86","shares_owned_after":5471.0,"shares_owned_after_display":"5,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2854270,"accession":"0001225208-24-006818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-006818","line_url":"/filing/0001225208-24-006818#line-2","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Cigna Group","issuer_ticker":"CI","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock, $.01 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":338.08,"price_display":"338.08","price_state":"stated","total_value":338080.0,"total_display":"338,080.00","shares_owned_after":5471.0,"shares_owned_after_display":"5,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider"},{"id":8724218,"accession":"0000950170-23-035681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-035681","line_url":"/filing/0000950170-23-035681#line-1","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34251.0,"shares_display":"34,251","price_per_share":0.7299,"price_display":"0.73","price_state":"stated","total_value":24999.8049,"total_display":"24,999.80","shares_owned_after":35851.0,"shares_owned_after_display":"35,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-27","filed_date":"2023-07-31","scope":"insider"},{"id":8281809,"accession":"0000950170-23-022874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-022874","line_url":"/filing/0000950170-23-022874#line-1","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":0.8672,"price_display":"0.87","price_state":"stated","total_value":520.32,"total_display":"520.32","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":8610955,"accession":"0001225208-23-003871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-23-003871","line_url":"/filing/0001225208-23-003871#line-1","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Cigna Group","issuer_ticker":"CI","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock, $.01 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322.0,"shares_display":"322","price_per_share":271.67,"price_display":"271.67","price_state":"stated","total_value":87477.74,"total_display":"87,477.74","shares_owned_after":4167.0,"shares_owned_after_display":"4,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-14","scope":"insider"},{"id":5088080,"accession":"0000899243-21-047110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-047110","line_url":"/filing/0000899243-21-047110#line-1","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.66,"price_display":"6.66","price_state":"stated","total_value":6660.0,"total_display":"6,660.00","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-07","scope":"insider"},{"id":4116053,"accession":"0001225208-21-009634","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-21-009634","line_url":"/filing/0001225208-21-009634#line-3","is_derivative":false,"issuer_cik":"0001625579","issuer_name":"Cigna Corp","issuer_ticker":"CI","issuer_name_source":null,"issuer_url":"/issuer/0001625579","owner_cik":"0001625579","owner_name":"Granger Elder","owner_url":"/insider/0001625579","role":"Director","officer_title":null,"security_title":"Common Stock, $.01 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4844.0,"shares_display":"4,844","price_per_share":237.06,"price_display":"237.06","price_state":"stated","total_value":1148318.64,"total_display":"1,148,318.64","shares_owned_after":3262.0,"shares_owned_after_display":"3,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001739940","name":"Cigna Group","url":"/issuer/0001739940","role":"Director","n_filings":5,"first_seen":"2021-06-28","last_seen":"2025-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001832415","name":"Better Therapeutics, Inc.","url":"/issuer/0001832415","role":"Director","n_filings":3,"first_seen":"2021-12-07","last_seen":"2023-07-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001625579","retrieved_at":"2026-08-21T18:09:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}